{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:58:07Z","timestamp":1775833087661,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Nasopharyngeal cancer (NPC) patients experience significant anatomical changes during radiation treatment (RT). Adaptive radiotherapy (ART) can be initiated in response to specific events or at scheduled intervals during treatment, prompting questions about patient selection, timing, and reliable triggers for re-CT and replanning. This study aimed to develop a method for selecting NPC patients for ART before treatment and identify the optimal timing for its implementation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>We retrospectively evaluated NPC patients treated at University Hospitals Leuven between 2016 and 2023, assessing volumetric changes in the parotid glands, air cavities, maxillary sinuses, and body contour at nasopharyngeal and low-neck levels throughout treatment. Structures were contoured on the initial simulation CT, weekly CBCTs, and final treatment day, resulting in eight measurements per parameter. Body contour changes were evaluated at the nasopharyngeal level (odontoid process) and neck level (lower edge of the third cervical vertebra). Measurements included volume, transverse diameters, and radius angles of 50\u00b0 and 310\u00b0. Kaplan-Meier analysis was used for overall survival (OS) and local control (LC), while longitudinal volumetric data were analyzed with linear mixed models. Continuous variables were dichotomized to create a binary variable, for the purpose to define cut-off values for significant predictive variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 47 NPC patients analyzed, 2- and 5-year loco-regional control rates were 95%, with overall survival rates of 100% and 93%, respectively. Significant reductions in parotid gland volume and body contour were observed, particularly between weeks 3 and 4. Predictors of parotid gland volume reduction included bulky nodal disease and larger initial parotid volume, with thresholds of 15 mm and 56 cc, respectively. Body contour changes during the fourth week correlated with high N-stage (\u2265 N3), higher initial BMI (&amp;gt;28 kg\/m\u00b2), bulky lymph nodes (15 mm), higher initial mean planned dose to the ipsilateral parotid gland (&amp;gt; 31 Gy) and larger initial primary tumor Clinical Target Volume (&amp;gt; 93 cc). Induction chemotherapy was significantly associated with fewer sinonasal air cavity changes than concomitant chemoradiotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>It is recommended to re-evaluate the RT plan during the period between fractions 15 and 20 of treatment. Patients treated for NCP could be selected for ART based on the following clinical criteria at diagnosis: N3 or higher classification, presence of a bulky lymph node larger than 15 millimeters, initial BMI exceeding 28 kg\/m\u00b2, mean planned dose to the ipsilateral parotid glands greater than 31 Gy, cumulative volume of the parotid glands greater than 56 cc, high-dose CTV of the primary tumor greater than 93 cc, and receiving RT with no prior induction chemotherapy. Validation of these pre-treatment clinical predictors in a large, prospective dataset is essential before clinical usage.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1653060","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:12:22Z","timestamp":1759119142000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Strategy to select nasopharyngeal cancer patients for adaptive radiotherapy"],"prefix":"10.3389","volume":"15","author":[{"given":"Heleen","family":"Bollen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Onorati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annouschka","family":"Laenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneleen","family":"Goedgebeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Nuyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0\/ATTACHMENT\/5B569C36-B93B-4C22-8319-D810C2BC476B\/MMC1.PDF","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/J.ANNONC.2020.12.007\/ATTACHMENT\/2F4A8739-D07D-45CE-8273-924808A8730C\/MMC1.PDF","article-title":"Nasopharyngeal carcinoma: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Bossi","year":"2021","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJROBP.2008.05.023","article-title":"Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma\u2014Patient- and treatment-related risk factors","volume":"73","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/J.RADONC.2012.08.013","article-title":"Prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. Conventional Two-Dimensional Radiotherapy for the Treatment of Nasopharyngeal Carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJROBP.2006.06.013","article-title":"Xerostomia and Quality of Life after Intensity-Modulated Radiotherapy vs. Conventional Radiotherapy for Early-Stage Nasopharyngeal Carcinoma: Initial Report on a Randomized Controlled Clinical Trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/J.RADONC.2024.110258","article-title":"Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis","volume":"195","author":"Dong","year":"2024","journal-title":"Radiother Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/S13014-019-1250-Z","article-title":"Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy","volume":"14","author":"Wang","year":"2019","journal-title":"Radiat Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.14338\/IJPT-20-00082.1","article-title":"Systematic review of proton therapy for the management of nasopharyngeal cancer","volume":"8","author":"Lee","year":"2021","journal-title":"Int J Part Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3390\/CANCERS14112587","article-title":"Proton therapy for squamous cell carcinoma of the head and neck: early clinical experience and current challenges","volume":"14","author":"Nuyts","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.03.007","article-title":"Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: an updated and expanded retrospective analysis","volume":"170","author":"Zhou","year":"2022","journal-title":"Radiother Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/CAM4.7192","article-title":"Adaptive radiotherapy for head and neck cancer: pitfalls and possibilities from the radiation oncologist\u2019s point of view","volume":"13","author":"Nuyts","year":"2024","journal-title":"Cancer Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/J.RADONC.2015.06.025","article-title":"Predicting the need for adaptive radiotherapy in head and neck cancer","volume":"116","author":"Brown","year":"2015","journal-title":"Radiother Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJROBP.2012.09.033","article-title":"Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma","volume":"85","author":"Yang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/J.RADONC.2012.03.013","article-title":"Prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients","volume":"104","author":"Cheng","year":"2012","journal-title":"Radiother Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"476383","DOI":"10.1155\/2015\/476383","article-title":"Replanning criteria and timing definition for parotid protection-based adaptive radiation therapy in nasopharyngeal carcinoma","volume":"2015","author":"Yao","year":"2015","journal-title":"BioMed Res Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLON.2011.11.005","article-title":"Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings: initial results","volume":"24","author":"Capelle","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/1533034617717624","article-title":"Prospective pilot study comparing the need for adaptive radiotherapy in unresected bulky disease and in postoperative patients with head and neck cancer","volume":"16","author":"Mahmoud","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1186\/S12885-018-5159-Y","article-title":"Which nasopharyngeal cancer patients need adaptive radiotherapy","volume":"18","author":"Hu","year":"2018","journal-title":"BMC Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13014-016-0650-6\/FIGURES\/6","article-title":"Nomogram to predict parotid gland overdose in head and neck IMRT","volume":"11","author":"Castelli","year":"2016","journal-title":"Radiat Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/J.RADONC.2015.05.018","article-title":"Identifying Patients Who May Benefit from Adaptive Radiotherapy: Does the Literature on Anatomic and Dosimetric Changes in Head and Neck Organs at Risk during Radiotherapy Provide Information to Help","volume":"115","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/J.RADONC.2016.05.025","article-title":"Selection of head and neck cancer patients for adaptive radiotherapy to decrease xerostomia","volume":"120","author":"Brouwer","year":"2016","journal-title":"Radiother Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109763","article-title":"An efficient strategy to select head and neck cancer patients for adaptive radiotherapy","volume":"186","author":"Gan","year":"2023","journal-title":"Radiother Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"20130363","DOI":"10.1259\/BJR.20130363","article-title":"Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy","volume":"86","author":"Sanguineti","year":"2013","journal-title":"Br J Radiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJROBP.2007.10.063","article-title":"Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration","volume":"70","author":"V\u00e1squez Osorio","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/J.RADONC.2009.12.014","article-title":"Two-variable linear model of parotid shrinkage during IMRT for head and neck cancer","volume":"94","author":"Broggi","year":"2010","journal-title":"Radiother Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/J.MEDDOS.2009.06.007","article-title":"Anatomic and dosimetric changes during the treatment course of intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma","volume":"35","author":"Wang","year":"2010","journal-title":"Med Dosim"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/S13014-015-0331-X","article-title":"Parotid gland shrinkage during IMRT predicts the time to xerostomia resolution","volume":"10","author":"Sanguineti","year":"2015","journal-title":"Radiat Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/S11547-014-0386-Z","article-title":"Volumetric and Positional Changes of Planning Target Volumes and Organs at Risk Using Computed Tomography Imaging during Intensity-Modulated Radiation Therapy for Head-Neck Cancer: An \u201cOld\u201d Adaptive Radiation Therapy Approach","volume":"119","author":"Reali","year":"2014","journal-title":"Radiol Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/AJCO.12516","article-title":"Head and neck adaptive radiotherapy: predicting the time to replan","volume":"12","author":"Brown","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"107224","DOI":"10.1016\/j.oraloncology.2025.107224","article-title":"Evaluation of a comprehensive set of normal tissue complication probability models for patients with head and neck cancer in an international cohort","volume":"163","author":"de Vette","year":"2025","journal-title":"Oral Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1653060\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:12:22Z","timestamp":1759119142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1653060\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":30,"alternative-id":["10.3389\/fonc.2025.1653060"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1653060","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"article-number":"1653060"}}